HealthQuill Dice Therapeutics
Eli Lilly and Company will acquire Dice Therapeutics for $2.4 billion to expand its immunology business, according to an online statement.
Drugs Health Pharma

Eli Lilly to acquire Dice Therapeutics by third quarter for $2.4 billion 

HQ Team June 20, 2023: Eli Lilly and Company will acquire Dice Therapeutics for $2.4 billion to expand its immunology business, according to an.

Read More
X